1. Home
  2. EHC vs RDY Comparison

EHC vs RDY Comparison

Compare EHC & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Encompass Health Corporation

EHC

Encompass Health Corporation

HOLD

Current Price

$97.64

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.74

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHC
RDY
Founded
1983
1984
Country
United States
India
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
11.6B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
EHC
RDY
Price
$97.64
$13.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$143.29
$16.90
AVG Volume (30 Days)
794.2K
1.9M
Earning Date
04-23-2026
05-08-2026
Dividend Yield
0.79%
0.52%
EPS Growth
24.22
N/A
EPS
5.54
N/A
Revenue
N/A
N/A
Revenue This Year
$9.38
$7.50
Revenue Next Year
$8.13
$2.96
P/E Ratio
$17.36
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$92.77
$12.26
52 Week High
$127.99
$16.17

Technical Indicators

Market Signals
Indicator
EHC
RDY
Relative Strength Index (RSI) 35.83 39.73
Support Level $92.77 $13.23
Resistance Level $109.14 $14.14
Average True Range (ATR) 2.91 0.23
MACD -1.04 -0.09
Stochastic Oscillator 14.55 14.36

Price Performance

Historical Comparison
EHC
RDY

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: